Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpinia galanga is a **plant species in the ginger family (Zingiberaceae)**, widely used both as a culinary spice and in traditional medicine systems including Unani, Ayurveda, and folk practices. The medicinal part is typically the **rhizome**, which contains essential oils (such as galangol, cineol, pinene, and eugenol) and active compounds like 1′-acetoxychavicol acetate. It is attributed with a range of pharmacological effects: **antimicrobial, anti-inflammatory, antioxidant, anticancer, antipsoriasis, antiallergic, neuroprotective, thermogenic, antiulcer, and prosexual activities**. It is particularly noted for its potential to **improve male sexual function**, possibly via androgenic activity, supported by a small clinical trial for SSRI-induced sexual dysfunction. The precise molecular mechanisms are largely unknown, but traditional and preclinical data suggest benefits in respiratory, digestive, infectious, inflammatory, and reproductive conditions. **Alpinia galanga is not a single pharmaceutical drug but a plant-derived dietary supplement, nutraceutical, and herbal medicine used broadly and sometimes included in multi-component herbal formulations**[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpinia galanga.